Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2005 4
2006 4
2007 3
2008 7
2009 3
2010 7
2011 4
2012 6
2013 10
2014 13
2015 12
2016 16
2017 13
2018 8
2019 16
2020 15
2021 17
2022 38
2023 19
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
hnRNPU is required for spermatogonial stem cell pool establishment in mice.
Wen Y, Zhou S, Gui Y, Li Z, Yin L, Xu W, Feng S, Ma X, Gan S, Xiong M, Dong J, Cheng K, Wang X, Yuan S. Wen Y, et al. Among authors: dong j. Cell Rep. 2024 Apr 23;43(4):114113. doi: 10.1016/j.celrep.2024.114113. Epub 2024 Apr 15. Cell Rep. 2024. PMID: 38625792 Free article.
VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms.
Zhang K, Zakeri A, Alban T, Dong J, Ta HM, Zalavadia AH, Branicky A, Zhao H, Juric I, Husich H, Parthasarathy PB, Rupani A, Drazba JA, Chakraborty AA, Ching-Cheng Huang S, Chan T, Avril S, Wang LL. Zhang K, et al. Among authors: dong j. Cell Rep. 2024 Jan 23;43(1):113661. doi: 10.1016/j.celrep.2023.113661. Epub 2024 Jan 3. Cell Rep. 2024. PMID: 38175754 Free PMC article.
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China.
Li J, Zhang J, Zhang Y, Qiu H, Zhou Y, Zhou Y, Zhang X, Zhou Y, Zhu Y, Li Y, Wang M, Shen K, Tao K, Wu X, Wang H, Zhang B, Ling J, Ye Y, Wu X, Qu H, Ma Y, Jiao X, Zheng H, Jin J, Liu Z, Tan M, Fang Y, Zhang P, Zhang N, Lei C, Cai Z, Liang B, Peng Z, Huang Z, Dong J, Shen L. Li J, et al. Among authors: dong j. Eur J Cancer. 2024 Jan;196:113439. doi: 10.1016/j.ejca.2023.113439. Epub 2023 Nov 14. Eur J Cancer. 2024. PMID: 37980854 Clinical Trial.
213 results